Depreciation in USD of Janux Therapeutics, Inc. from 2020 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Janux Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to Q1 2025.
  • Janux Therapeutics, Inc. Depreciation for the quarter ending March 31, 2025 was $519K, a 2.44% decline year-over-year.
  • Janux Therapeutics, Inc. annual Depreciation for 2024 was $2.06M, a 5.37% increase from 2023.
  • Janux Therapeutics, Inc. annual Depreciation for 2023 was $1.96M, a 132% increase from 2022.
  • Janux Therapeutics, Inc. annual Depreciation for 2022 was $841K, a 644% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

Janux Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $519K -$13K -2.44% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q1 2024 $532K +$79K +17.4% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q1 2023 $453K +$372K +459% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 $81K +$72K +800% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $9K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10

Janux Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $2.06M +$105K +5.37% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 $1.96M +$1.11M +132% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $841K +$728K +644% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 $113K +$100K +769% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 $13K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.